Harpreet Singh
13PUBLICATIONS
104CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Nov 12, 2024
Administrative Aspects of Molecular Diagnostics-Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models.Lalan Wilfong, Lauren Baggett, Philip Reena
|Oct 07, 2024
The Retrofit: Lessons From Sotorasib's Dosing Conundrum.Harpreet Singh, Paz J Vellanki, Richard Pazdur
|Jun 25, 2024
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.Elizabeth S Duke, Diana Bradford, Arup K Sinha
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Feb 15, 2024
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.Jason Fangusaro, Robert A Avery, Michael J Fisher
Pageof 3
Frequent Collaborators
9 joint publications
Richard Pazdur
7 joint publications
Pallavi S Mishra-Kalyani
6 joint publications
Diana Bradford
5 joint publications
Paul G Kluetz
5 joint publications
Nicole Drezner
5 joint publications
Youwei Bi
5 joint publications
Martha Donoghue
5 joint publications
Barbara Scepura
4 joint publications
Elizabeth S Duke
4 joint publications
Jeanne Fourie Zirkelbach
